Filtered By:
Source: ESC Heart Failure
Condition: Heart Failure
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 167 results found since Jan 2013.
Modification of ventriculo –arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
ConclusionsIn NIDCM, adding MRA to conventional anti ‐failure therapy markedly improved LV ejection fraction and reduced peripheral vascular resistance, due to both improved LV contractility and especially to enhanced V–A coupling, as Ea decreased to normal. Total circulatory performance was a sensitive indicator of both LV pump performance and th e arterial loading conditions.
Source: ESC Heart Failure - January 5, 2021 Category: Cardiology Authors: Mark A. Lawson,
David E. Hansen,
Deepak K. Gupta,
Susan P. Bell,
Douglas W. Adkisson,
Ravinder R. Mallugari,
Douglas B. Sawyer,
Henry Ooi,
Marvin W. Kronenberg Tags: Original Research Article Source Type: research
Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation
ConclusionsLeft ventricular assist device therapy can impair the outcome after HTx. However, the occurrence of LVAD complications may not impact on outcome after HTx. Thus, we cannot support the prioritization or discrimination of HTx candidates according to distinct mechanical circulatory support ‐associated complications. Future allocation strategies have to respect that device‐related complications may define urgency but do not impact on the outcome after HTx.
Source: ESC Heart Failure - January 21, 2021 Category: Cardiology Authors: Moritz Benjamin Immohr,
Udo Boeken,
Franziska Mueller,
Emir Prashovikj,
Michiel Morshuis,
Charlotte B öttger,
Hug Aubin,
Jan Gummert,
Payam Akhyari,
Artur Lichtenberg,
René Schramm Tags: Original Research Article Source Type: research
Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
ConclusionsLevosimendan may be a safe and effective alternative for pulmonary hypertension reversibility assessment or a valuable pre ‐test medical optimization tool in end‐stage heart failure patient assessment for heart transplantation offering extended haemodynamic benefits. Whether it increases the rate of positive responses or allows a better selection of candidates to heart transplantation remains to be established.
Source: ESC Heart Failure - February 23, 2021 Category: Cardiology Authors: Marta Tavares ‐Silva,
Francisca Saraiva,
Roberto Pinto,
Sandra Amorim,
João Carlos Silva,
Adelino F. Leite‐Moreira,
Maria Júlia Maciel,
André P. Lourenço Tags: Original Research Article Source Type: research
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
ConclusionsParticipants on baseline diuretics derived a greater benefit for major cardiovascular events from canagliflozin, which was not fully explained by differences in participant characteristics nor risk factor changes.
Source: ESC Heart Failure - February 17, 2021 Category: Cardiology Authors: Jie Yu,
Clare Arnott,
Brendon L. Neuen,
Hiddo L. Heersprink,
Kenneth W. Mahaffey,
Christopher P. Cannon,
Sadiya S. Khan,
Abigail S. Baldridge,
Sanjiv J. Shah,
Yuli Huang,
Chao Li,
Gemma A. Figtree,
Vlado Perkovic,
Meg J. Jardine,
Bruce Neal, Tags: Original Research Article Source Type: research
Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
ConclusionsLevosimendan may be a safe and effective alternative for pulmonary hypertension reversibility assessment or a valuable pre ‐test medical optimization tool in end‐stage heart failure patient assessment for heart transplantation offering extended haemodynamic benefits. Whether it increases the rate of positive responses or allows a better selection of candidates to heart transplantation remains to be established.
Source: ESC Heart Failure - February 23, 2021 Category: Cardiology Authors: Marta Tavares ‐Silva,
Francisca Saraiva,
Roberto Pinto,
Sandra Amorim,
João Carlos Silva,
Adelino F. Leite‐Moreira,
Maria Júlia Maciel,
André P. Lourenço Tags: Original Research Article Source Type: research
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
ConclusionsParticipants on baseline diuretics derived a greater benefit for major cardiovascular events from canagliflozin, which was not fully explained by differences in participant characteristics nor risk factor changes.
Source: ESC Heart Failure - February 17, 2021 Category: Cardiology Authors: Jie Yu,
Clare Arnott,
Brendon L. Neuen,
Hiddo L. Heersprink,
Kenneth W. Mahaffey,
Christopher P. Cannon,
Sadiya S. Khan,
Abigail S. Baldridge,
Sanjiv J. Shah,
Yuli Huang,
Chao Li,
Gemma A. Figtree,
Vlado Perkovic,
Meg J. Jardine,
Bruce Neal, Tags: Original Research Article Source Type: research
Cardiac output changes during exercise in heart failure patients: focus on mid ‐exercise
ConclusionsMid ‐exercise VO2 and CO portend peak exercise values and identify severe HF patients. Their evaluation could be clinically useful.
Source: ESC Heart Failure - January 25, 2021 Category: Cardiology Authors: Nicoletta Corrieri,
Alberico Del Torto,
Carlo Vignati,
Riccardo Maragna,
Fabiana De Martino,
Martina Cellamare,
Stefania Farina,
Elisabetta Salvioni,
Alice Bonomi,
Piergiuseppe Agostoni Tags: Original Research Article Source Type: research
Prognostic value of the H2FPEF score in patients undergoing transcatheter aortic valve implantation
ConclusionsThe H2FPEF score serves as an independent predictor of adverse CV and heart failure outcome among TAVI patients with preserved EF. A high H2FPEF score is associated with the presence of paradoxical low ‐flow, low‐gradient AS, the HFpEF in patients with AS. By identifying patients in advanced stages of HFpEF, the H2FPEF score might be useful as a risk prediction tool in patients with preserved EF scheduled for TAVI.
Source: ESC Heart Failure - January 25, 2021 Category: Cardiology Authors: Sebastian Ludwig,
Costanza Pellegrini,
Alina Gossling,
Tobias Rheude,
Lisa Voigtl änder,
Oliver D. Bhadra,
Matthias Linder,
Daniel Kalbacher,
Benedikt Koell,
Lara Waldschmidt,
Johannes Schirmer,
Moritz Seiffert,
Hermann Reichenspurner,
Stefa Tags: Original Research Article Source Type: research
Modification of ventriculo –arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
ConclusionsIn NIDCM, adding MRA to conventional anti ‐failure therapy markedly improved LV ejection fraction and reduced peripheral vascular resistance, due to both improved LV contractility and especially to enhanced V–A coupling, as Ea decreased to normal. Total circulatory performance was a sensitive indicator of both LV pump performance and th e arterial loading conditions.
Source: ESC Heart Failure - March 29, 2021 Category: Cardiology Authors: Mark A. Lawson,
David E. Hansen,
Deepak K. Gupta,
Susan P. Bell,
Douglas W. Adkisson,
Ravinder R. Mallugari,
Douglas B. Sawyer,
Henry Ooi,
Marvin W. Kronenberg Tags: Original Research Article Source Type: research
Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation
ConclusionsLeft ventricular assist device therapy can impair the outcome after HTx. However, the occurrence of LVAD complications may not impact on outcome after HTx. Thus, we cannot support the prioritization or discrimination of HTx candidates according to distinct mechanical circulatory support ‐associated complications. Future allocation strategies have to respect that device‐related complications may define urgency but do not impact on the outcome after HTx.
Source: ESC Heart Failure - March 29, 2021 Category: Cardiology Authors: Moritz Benjamin Immohr,
Udo Boeken,
Franziska Mueller,
Emir Prashovikj,
Michiel Morshuis,
Charlotte B öttger,
Hug Aubin,
Jan Gummert,
Payam Akhyari,
Artur Lichtenberg,
René Schramm Tags: Original Research Article Source Type: research
Fibrosis ‐4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction
ConclusionsAn increase in the FIB ‐4 index was associated with right ventricular dysfunction and a higher risk of future MACE in patients with HFpEF.
Source: ESC Heart Failure - March 24, 2021 Category: Cardiology Authors: Mitsutaka Nakashima,
Satoru Sakuragi,
Toru Miyoshi,
Shin Takayama,
Tatsuto Kawaguchi,
Nobuhisa Kodera,
Hiroaki Akai,
Yuji Koide,
Hiroaki Otsuka,
Tadashi Wada,
Kenji Kawamoto,
Machiko Tanakaya,
Yusuke Katayama,
Hiroshi Ito Tags: Original Research Article Source Type: research
Myocardial work index: a marker of left ventricular contractility in pressure ‐induced or volume overload‐induced heart failure
ConclusionsBeing significantly influenced by loading conditions, GLS may not be a reliable marker of LV contractility in heart failure induced by pressure or volume overload. GMWI better reflects contractility in haemodynamic overload states, making it a more robust marker of systolic function, while GLS should be considered as an integrative marker, incorporating systolic function, haemodynamic loading state, and adverse tissue remodelling of the LV.
Source: ESC Heart Failure - March 23, 2021 Category: Cardiology Authors: B álint Károly Lakatos,
Mihály Ruppert,
Márton Tokodi,
Attila Oláh,
Szilveszter Braun,
Christian Karime,
Zsuzsanna Ladányi,
Alex Ali Sayour,
Bálint András Barta,
Béla Merkely,
Tamás Radovits,
Attila Kovács Tags: Original Research Article Source Type: research
Urinary N ‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
ConclusionsUrinary NT ‐proBNP seems to provide a significant predictive value regarding the endpoints all‐cause mortality and major adverse cardiac events in patients with acute chest pain and those with ACS.
Source: ESC Heart Failure - April 7, 2021 Category: Cardiology Authors: Stefanie Reynen,
Michael Schlossbauer,
Ute Hubauer,
Julian Hupf,
Arno Mohr,
Evelyn Orso,
Markus Zimmermann,
Andreas Luchner,
Lars S. Maier,
Stefan Wallner,
Carsten G. Jungbauer Tags: Original Research Article Source Type: research
A mid ‐ventricular variant of Takotsubo syndrome: was it triggered by insular cortex damage?
We report the case of a 79 ‐year‐old female diagnosed with a mid‐ventricular variant of TTS concomitant with right IC ischaemic stroke. After 12 h of hospitalization, she experienced a sudden collapse. Rapid cardiopulmonary resuscitation resulted in a return of spontaneous circulation. Subsequent left ventriculography revealed akinesis in the mid‐portion of the left ventricle with vigorous contraction of the basal and apex segment. Two weeks after admission, cardiac ultrasound showed improved left ventricular contraction. Right IC ischaemia in this patient might have been associated with a dysregulation of the CAN...
Source: ESC Heart Failure - May 3, 2021 Category: Cardiology Authors: Ayano Osawa,
Michiaki Nagai,
Keigo Dote,
Masaya Kato,
Noboru Oda,
Eiji Kunita,
Eisuke Kagawa,
Aya Yamane,
Hiroshi Kobatake,
Haruko Shiota,
Naoki Ishibashi,
Kazuki Takahashi,
Carola Y. F örster Tags: Case Report Source Type: research
Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction
ConclusionsThe RV ‐PA coupling ratio Ees/Ea predicts overall survival in PH due to HFREF and is mainly affected by pulsatile load, RV remodelling, and left ventricular dysfunction. Prognostically favourable coupling (RV‐Ees/Ea ≥ 0.68) in PH was associated with preserved RV size/function and mid‐term surviva l, comparable with HFREF without PH.
Source: ESC Heart Failure - May 2, 2021 Category: Cardiology Authors: Alexander Schmei ßer,
Thomas Rauwolf,
Thomas Groscheck,
Katharina Fischbach,
Siegfried Kropf,
Blerim Luani,
Ivan Tanev,
Michael Hansen,
Saskia Meißler,
Kerstin Schäfer,
Paul Steendijk,
Ruediger C. Braun‐Dullaeus Tags: Original Research Article Source Type: research
